Erin R. Weeda

1.5k total citations
83 papers, 918 citations indexed

About

Erin R. Weeda is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Erin R. Weeda has authored 83 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 21 papers in Internal Medicine and 16 papers in Epidemiology. Recurrent topics in Erin R. Weeda's work include Venous Thromboembolism Diagnosis and Management (21 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Acute Ischemic Stroke Management (12 papers). Erin R. Weeda is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (21 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Acute Ischemic Stroke Management (12 papers). Erin R. Weeda collaborates with scholars based in United States, Canada and Australia. Erin R. Weeda's co-authors include Craig I Coleman, Elaine Nguyen, Diana M Sobieraj, C Michael White, William L. Baker, Kathryn Blake, Jason E. Lang, Stephen C. Lazarus, Concetta Crivera and Jeff Schein and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Erin R. Weeda

78 papers receiving 899 citations

Peers

Countries citing papers authored by Erin R. Weeda

Since Specialization

Citations

This map shows the geographic impact of Erin R. Weeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin R. Weeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin R. Weeda more than expected).

Fields of papers citing papers by Erin R. Weeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin R. Weeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin R. Weeda. The network helps show where Erin R. Weeda may publish in the future.

Co-authorship network of co-authors of Erin R. Weeda

This figure shows the co-authorship network connecting the top 25 collaborators of Erin R. Weeda. A scholar is included among the top collaborators of Erin R. Weeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin R. Weeda. Erin R. Weeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Medication adherence to sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists: A meta‐analysis 2024 ·Diabetes Obesity and Metabolism ·(unknown), (unknown), Erin R. Weeda	3
2	Cannabinoids for obstructive sleep apnea: A systematic review 2024 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), (unknown), Jennifer E. Thomas, Erin R. Weeda, (unknown), Joshua Caballero	0
3	Impact of Cytogenetic Abnormalities, Induction and Maintenance Regimens on Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma: A Decade-Long Real-World Experience 2023 ·Journal of Hematology ·(unknown), (unknown), James A. Davis, (unknown), Erin R. Weeda, Arash Velayati, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hamza Hashmi	0
4	Risk factors for predicting extended-spectrum β-lactamase-producing Enterobacterales (ESBLE) infections in non-urinary isolates 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Erin R. Weeda, (unknown), (unknown)	1
5	Effectiveness, Safety, and Cost Implications of Outpatient Autologous Hematopoietic Stem Cell Transplant for Multiple Myeloma 2023 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), (unknown), Erin R. Weeda, Amarendra Kumar Neppalli, Hamza Hashmi, (unknown)	0
6	Association between duration of antipseudomonal beta-lactam therapy and Clostridioides difficile infections in monomicrobial Enterobacterales bloodstream infections at an academic medical center 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Erin R. Weeda, (unknown)	5
7	Trends in prescribing as-needed inhaled corticosteroid (ICS)-Formoterol for patients with asthma 2022 ·Respiratory Medicine ·(unknown), (unknown), Erin R. Weeda, Sandra S. Garner	0
8	Clinical utility of negative methicillin-resistant Staphylococcus aureus (MRSA) nasal surveillance swabs in skin and skin structure infections 2021 ·American Journal of Infection Control ·(unknown), Erin R. Weeda, (unknown), (unknown)	7
9	Advanced models for improved prediction of opioid-related overdose and suicide events among Veterans using administrative healthcare data 2021 ·Health Services and Outcomes Research Methodology ·Ralph Ward, Erin R. Weeda, David J. Taber, R. Neal Axon, Mulugeta Gebregziabher	1
10	Impact of Pharmacist-Driven Transitions of Care Interventions on Post-hospital Outcomes Among Patients With Coronary Artery Disease: A Systematic Review 2021 ·Journal of Pharmacy Practice ·Erin R. Weeda, (unknown), (unknown), (unknown), (unknown), David J. Taber, R. Neal Axon	10
11	Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study 2020 ·BMC Cardiovascular Disorders ·Erin R. Weeda, Kinfe G. Bishu, Ralph Ward, R. Neal Axon, David J. Taber, Mulugeta Gebregziabher	6
12	Racial–Geographic Disparity in Lipid Management in Veterans with Type 2 Diabetes: A 10-Year Retrospective Cohort Study 2019 ·Health Equity ·Elizabeth A. Brown, Ralph Ward, Erin R. Weeda, David J. Taber, R. Neal Axon, Mulugeta Gebregziabher	6
13	Impact of De-Identification on Clinical Text Classification Using Traditional and Deep Learning Classifiers 2019 ·Studies in health technology and informatics ·Jihad S. Obeid, (unknown), Erin R. Weeda, (unknown), Christine Carr, (unknown), (unknown), Stéphane M. Meystre	15
14	Saddle pulmonary embolism and in-hospital mortality in patients with cancer 2019 ·International Journal of Clinical Oncology ·(unknown), (unknown), Erin R. Weeda	3
15	Weight-based versus non-weight-based diltiazem dosing in the setting of atrial fibrillation with rapid ventricular response 2019 ·The American Journal of Emergency Medicine ·(unknown), (unknown), (unknown), (unknown), Gregory A. Hall, (unknown), Erin R. Weeda, Kyle A. Weant	8
16	Association between comorbid cancer and outcomes among admissions for acute ischemic stroke receiving systemic thrombolysis 2018 ·International Journal of Stroke ·Erin R. Weeda, Nicole Bohm	22
17	Abstract 16513: Effectiveness and Safety of Rivaroxaban versus Warfarin in Patients 80+ Years of Age With Nonvalvular Atrial Fibrillation 2017 ·Circulation ·Craig I Coleman, Erin R. Weeda, Elaine Nguyen, Thomas J. Bunz, Nitesh Sood	1
18	IS RIVAROXABAN ASSOCIATED WITH SHORTER INPATIENT STAYS AND LOWER HOSPITAL COSTS VERSUS HEPARIN/WARFARIN IN LOW-RISK PULMONARY EMBOLISM PATIENTS? 2016 ·Journal of the American College of Cardiology ·Craig I Coleman, Erin R. Weeda, W. Frank Peacock, Gregory J. Fermann, Concetta Crivera, Jeff Schein, Christine G. Kohn	1
19	Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism 2016 ·Journal of Thrombosis and Thrombolysis ·Erin R. Weeda, W. Frank Peacock, Gregory J. Fermann, Philip S. Wells, Veronica Ashton, Concetta Crivera, Thomas J. Bunz, Peter Wildgoose, Jeff Schein, Craig I Coleman	5
20	External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications 2016 ·BMC Health Services Research ·Craig I Coleman, W. Frank Peacock, Gregory J. Fermann, Concetta Crivera, Erin R. Weeda, Michael Hüll, (unknown), Laura Becker, Jeff Schein	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact